Nuveen’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $90.4M | Sell |
999,912
-116,413
| -10% | -$10.7M | 0.02% | 424 |
|
|
2025
Q4 | $100M | Sell |
1,116,325
-19,101
| -2% | -$1.81M | 0.03% | 399 |
|
|
2025
Q3 | $112M | Sell |
1,135,426
-99,289
| -8% | -$9.84M | 0.03% | 380 |
|
|
2025
Q2 | $113M | Sell |
1,234,715
-142,659
| -10% | -$13.8M | 0.03% | 370 |
|
|
2025
Q1 | $156M | Sell |
1,377,374
-12,031
| -0.9% | -$1.29M | 0.05% | 305 |
|
|
2024
Q4 | $147M | Buy |
1,389,405
+913,310
| +192% | +$98M | 0.04% | 317 |
|
|
2024
Q3 | $51.4M | Sell |
476,095
-294,517
| -38% | -$32.1M | 0.01% | 646 |
|
|
2024
Q2 | $83.7M | Buy |
770,612
+133,644
| +21% | +$15.8M | 0.02% | 457 |
|
|
2024
Q1 | $84.1M | Sell |
636,968
-85,323
| -12% | -$10.7M | 0.02% | 466 |
|
|
2023
Q4 | $87.9M | Sell |
722,291
-214,365
| -23% | -$23.9M | 0.03% | 434 |
|
|
2023
Q3 | $105M | Sell |
936,656
-368,152
| -28% | -$46.8M | 0.04% | 357 |
|
|
2023
Q2 | $190M | Buy |
1,304,808
+108,238
| +9% | +$14.7M | 0.07% | 238 |
|
|
2023
Q1 | $155M | Buy |
1,196,570
+118,665
| +11% | +$14.9M | 0.06% | 281 |
|
|
2022
Q4 | $137M | Sell |
1,077,905
-260,720
| -19% | -$30.3M | 0.05% | 308 |
|
|
2022
Q3 | $140M | Sell |
1,338,625
-183,548
| -12% | -$20.1M | 0.06% | 301 |
|
|
2022
Q2 | $160M | Buy |
1,522,173
+112,077
| +8% | +$13.3M | 0.06% | 284 |
|
|
2022
Q1 | $171M | Sell |
1,410,096
-768,453
| -35% | -$92.6M | 0.06% | 293 |
|
|
2021
Q4 | $269M | Sell |
2,178,549
-643,250
| -23% | -$84.2M | 0.08% | 221 |
|
|
2021
Q3 | $401M | Sell |
2,821,799
-1,291,035
| -31% | -$190M | 0.12% | 156 |
|
|
2021
Q2 | $642M | Sell |
4,112,834
-112,175
| -3% | -$18.2M | 0.19% | 109 |
|
|
2021
Q1 | $657M | Sell |
4,225,009
-262,315
| -6% | -$40.6M | 0.21% | 102 |
|
|
2020
Q4 | $671M | Sell |
4,487,324
-149,566
| -3% | -$21.1M | 0.23% | 85 |
|
|
2020
Q3 | $613M | Buy |
4,636,890
+405,977
| +10% | +$53M | 0.24% | 86 |
|
|
2020
Q2 | $490M | Buy |
4,230,913
+291,247
| +7% | +$33.6M | 0.2% | 95 |
|
|
2020
Q1 | $387M | Sell |
3,939,666
-485,358
| -11% | -$63.6M | 0.19% | 115 |
|
|
2019
Q4 | $643M | Sell |
4,425,024
-63,751
| -1% | -$8.8M | 0.24% | 85 |
|
|
2019
Q3 | $598M | Buy |
4,488,775
+102,711
| +2% | +$13.3M | 0.24% | 86 |
|
|
2019
Q2 | $501M | Buy |
4,386,064
+4,271,400
| +3,725% | +$500M | 0.2% | 99 |
|
|
2019
Q1 | $14.2M | Sell |
114,664
-9,234
| -7% | -$1.05M | 0.08% | 349 |
|
|
2018
Q4 | $12.5M | Sell |
123,898
-109,717
| -47% | -$12.3M | 0.08% | 360 |
|
|
2018
Q3 | $29.8M | Buy |
233,615
+35,500
| +18% | +$4.22M | 0.16% | 202 |
|
|
2018
Q2 | $21.4M | Buy |
198,115
+166,042
| +518% | +$18.1M | 0.13% | 228 |
|
|
2018
Q1 | $3.4M | Sell |
32,073
-415
| -1% | -$48.2K | 0.02% | 518 |
|
|
2017
Q4 | $3.81M | Buy |
32,488
+8,100
| +33% | +$916K | 0.02% | 494 |
|
|
2017
Q3 | $2.77M | Buy |
24,388
+824
| +3% | +$95.1K | 0.02% | 570 |
|
|
2017
Q2 | $2.94M | Sell |
23,564
-7,594
| -24% | -$900K | 0.02% | 558 |
|
|
2017
Q1 | $3.69M | Sell |
31,158
-17,305
| -36% | -$1.96M | 0.02% | 559 |
|
|
2016
Q4 | $4.86M | Buy |
48,463
+8,883
| +22% | +$952K | 0.02% | 615 |
|
|
2016
Q3 | $5M | Sell |
39,580
-1,221
| -3% | -$151K | 0.03% | 530 |
|
|
2016
Q2 | $4.77M | Buy |
40,801
+2,525
| +7% | +$286K | 0.03% | 505 |
|
|
2016
Q1 | $3.96K | Sell |
38,276
-166
| -0.4% | -$16.1K | 0.02% | 528 |
|
|
2015
Q4 | $3.83K | Buy |
38,442
+2,308
| +6% | +$226K | 0.02% | 537 |
|
|
2015
Q3 | $3.29K | Buy |
36,134
+504
| +1% | +$50.5K | 0.02% | 590 |
|
|
2015
Q2 | $3.78K | Sell |
35,630
-4,269
| -11% | -$472K | 0.02% | 585 |
|
|
2015
Q1 | $4.55M | Buy |
39,899
+16,602
| +71% | +$1.89M | 0.02% | 545 |
|
|
2014
Q4 | $2.56M | Sell |
23,297
-42,491
| -65% | -$4.48M | 0.01% | 748 |
|
|
2014
Q3 | $6.42M | Buy |
65,788
+5,918
| +10% | +$582K | 0.04% | 466 |
|
|
2014
Q2 | $6.04M | Buy |
59,870
+43,883
| +274% | +$4.28M | 0.04% | 512 |
|
|
2014
Q1 | $1.47M | Sell |
15,987
-361
| -2% | -$33.3K | 0.01% | 942 |
|
|
2013
Q4 | $1.48M | Sell |
16,348
-3,993
| -20% | -$346K | 0.01% | 901 |
|
|
2013
Q3 | $1.62M | Buy |
20,341
+2,147
| +12% | +$169K | 0.01% | 901 |
|
|
2013
Q2 | $1.32M | Buy |
+18,194
| New | +$1.36M | 0.01% | 917 |
|
Other funds holding ZBH
VCM
VPM
Nuveen's ZBH Position: Q1 2026 in Review
Nuveen reduced its Zimmer Biomet (ZBH) stake by 10% in Q1 2026, selling an estimated $10.7M and leaving 999,912 shares worth $90.4M. The position accounts for 0.02% of the portfolio, ranked #424.
Nuveen first reported a position in ZBH in Q2 2013 and has held it in 52 quarters since. The position peaked at $671M in Q4 2020. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.
- Nuveen held 999,912 shares of Zimmer Biomet worth $90.4M as of Q1 2026.
- Nuveen sold 116,413 Zimmer Biomet shares in Q1 2026, an estimated $10.7M.
- Zimmer Biomet made up 0.02% of Nuveen's portfolio in Q1 2026, its #424 holding.
- Nuveen first reported a position in Zimmer Biomet in Q2 2013 and has held it in 52 quarters since.
- Nuveen's Zimmer Biomet position peaked at $671M in Q4 2020.
- 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.
Based on Nuveen's 13F filing for Q1 2026, filed 30 Apr 2026.